Cover Image
Market Research Report
Product code 
1097590

Dermatology Devices Market by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) - Global Forecast to 2027

Published: | MarketsandMarkets | 242 Pages | Delivery time: 1-2 business days

Price

Back to Top
Dermatology Devices Market by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) - Global Forecast to 2027
Published: June 29, 2022
MarketsandMarkets
Content info: 242 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global dermatology devices market is projected to reach USD 11.3 billion by 2027 from USD 6.2 billion in 2022, at a CAGR of 12.7% during the forecasted period. Dermatology devices help dermatologists and surgeons in diagnosing and treating skin disorders. These devices are used by various medical care providers, such as hospitals, dermatology clinics, physician offices, and academic research institutes. The rising incidence of skin diseases and increasing awareness of aesthetic procedures are the primary growth drivers for the dermatology devices market. The expansion of healthcare infrastructure in developing regions is expected to provide growth opportunities to players operating in this market.

"The imaging devices areaccounted to hold the largest share of the dermatology diagnostic devices market, by type in 2021."

Based on type, the dermatology diagnostic devices market is segmented into imaging devices, dermatoscopes, and microscopes. In 2021, the imaging devices segment accounted for the largest share of the dermatology diagnostic devices market. The large share of this segment can be attributed to technological advancements and the increasing incidence of skin diseases.

"The skin cancer diagnosis are accounted to hold the largest share of the dermatology diagnostic devices market, by application in 2021."

Based on application, the dermatology diagnostic devices market is segmented into skin cancer diagnosis and other diagnostic applications. In 2021, the skin cancer diagnosis segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising incidence of skin cancer.

"Asia Pacific commanded the highest CAGR of the dermatology devices duringforecasted period."

Based on region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. During forecasted period, Asia Pacific has the highest CAGR of the dermatology devices market. The highest CAGR of this regional segment can be attributed to factors such as the large population, rising standards of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about dermatology devices.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
  • By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
  • By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)

Some of the major players operating in this market Lumenis Ltd. (Israel),, Alma Lasers, Ltd.(US), Solta Medical (US), and Cutera, Inc.(US)

List of Companies Profiled in the Report

  • Alma Lasers, Ltd. (Israel)
  • Cutera, Inc. (US)
  • Cynosure Inc. (US)
  • El.En. S.P.A. (Italy)
  • Lumenis Ltd. (Israel)
  • Solta Medical (US)
  • Bruker Corporation (US)
  • Carl Zeiss (Germany)
  • HEINE Optotechnik GmbH & Co. KG (Germany)
  • Michelson Diagnostics Ltd. (UK)
  • PhotoMedex, Inc. (US)
  • Leica Microsystems (US)
  • Olympus Corporation (Japan)
  • Syneron Medical Ltd. (US)
  • Genesis Biosystems, Inc. (US)
  • Canfield Scientific, Inc. (US)
  • Candela (US)
  • DermLite (US)
  • Beijing Toplaser Technology Co., Ltd. (China)
  • Aerolase (US)
  • FotoFinder Systems GmbH (Germany)
  • Bovie (US)

Research Coverage

This report studies the dermatology devices market based on type, application, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total dermatology devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on dermatology devices offered by the top 22 players in the endoscope reprocessing market. The report analyzes the dermatology devices markettype,application,and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the dermatology devices market
Product Code: MD 3107

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY - BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY - BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT/FACTOR ANALYSIS
    • TABLE 1 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 DERMATOLOGY DEVICES MARKET OVERVIEW
    • FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021)
    • FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021
  • 4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET
    • FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of skin disorders
      • 5.2.1.2 Availability of technologically advanced and user-friendly products
      • 5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures
      • 5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals
    • FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
    • FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
      • 5.2.1.5 Increasing investments, funds, and grants by public-private organizations
    • TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory policies for medical devices
      • 5.2.2.2 Clinical risks and complications associated with dermatology procedures
      • 5.2.2.3 High cost of diagnostic imaging systems
      • 5.2.2.4 Declining reimbursements and increasing regulatory burden in the US
    • TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007-2019
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing medical devices industry in emerging economies
    • FIGURE 22 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)
      • 5.2.3.2 Increasing disposable income and expanding middle-class population
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes
      • 5.2.4.2 Dearth of trained professionals
    • 5.2.5 TRENDS
      • 5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment
  • 5.3 COVID-19 IMPACT ANALYSIS
  • 5.4 RANGES/SCENARIOS
    • 5.4.1 DERMATOLOGY DEVICES MARKET
    • FIGURE 23 REALISTIC SCENARIO
    • FIGURE 24 PESSIMISTIC SCENARIO
    • FIGURE 25 OPTIMISTIC SCENARIO
  • 5.5 REGULATORY ANALYSIS
    • TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.5.2 EUROPE
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
    • TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
      • 5.5.3.2 China
    • TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.3.3 India
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 DIRECT DISTRIBUTION-PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.9 ECOSYSTEM ANALYSIS
    • FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS
    • 5.9.1 ROLE IN ECOSYSTEM
    • FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM
  • 5.10 TECHNOLOGY ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES
    • FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011-JUNE 2022
    • FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011-JUNE 2022
    • 5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DERMATOSCOPE PATENTS, JANUARY 2011-JUNE 2022
    • FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011-JUNE 2022
  • 5.13 TRADE ANALYSIS
    • TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017-2021 (USD MILLION)
  • 5.14 PRICING ANALYSIS
    • TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES
    • TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES
    • TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%)
    • 5.15.2 BUYING CRITERIA
    • FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF DERMATOLOGY TREATMENT DEVICES
    • TABLE 16 KEY BUYING CRITERIA FOR END USERS OF DERMATOLOGY TREATMENT DEVICES
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
    • 5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS
    • FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES

6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 IMAGING DEVICES
    • 6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS
    • TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 DERMATOSCOPES
    • 6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH
    • TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 MICROSCOPES
    • 6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES - A KEY FACTOR DRIVING SEGMENT GROWTH
    • TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY REGION, 2020-2027 (USD MILLION)

7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 7.2 SKIN CANCER DIAGNOSIS
    • 7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH
    • TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
    • TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
    • TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
    • TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
    • TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 OTHER DIAGNOSTIC APPLICATIONS
    • TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 8.2 LIGHT THERAPY DEVICES
    • 8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES TO DRIVE SEGMENT GROWTH
    • TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 LASERS
    • 8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS
    • TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 ELECTROSURGICAL EQUIPMENT
    • 8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH
    • TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.5 LIPOSUCTION DEVICES
    • 8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH
    • TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020-2027 (USD MILLION)
  • 8.6 MICRODERMABRASION DEVICES
    • 8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
    • TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020-2027 (USD MILLION)
  • 8.7 CRYOTHERAPY DEVICES
    • 8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION
    • TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020-2027 (USD MILLION)

9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.2 HAIR REMOVAL
    • 9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES
    • TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
    • TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 SKIN REJUVENATION
    • 9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH
    • TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL
    • 9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH
    • TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
    • TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 WRINKLE REMOVAL AND SKIN RESURFACING
    • 9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH
    • TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020)
    • TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020-2027 (USD MILLION)
  • 9.6 BODY CONTOURING AND FAT REMOVAL
    • 9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY TO DRIVE SEGMENT GROWTH
    • TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020)
    • TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020)
    • TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020-2027 (USD MILLION)
  • 9.7 VASCULAR AND PIGMENTED LESION REMOVAL
    • 9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH
    • TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020-2027 (USD MILLION)
  • 9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT
    • 9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT
    • TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020-2027 (USD MILLION)
  • 9.9 OTHER TREATMENT APPLICATIONS
    • TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

10 DERMATOLOGY DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT
    • TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US dominated North American market in 2021
    • TABLE 55 US: KEY MACROINDICATORS
    • TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada
    • TABLE 64 CANADA: KEY MACROINDICATORS
    • TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.1 FRANCE
      • 10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries
    • TABLE 74 FRANCE: KEY MACROINDICATORS
    • TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany
    • TABLE 81 GERMANY: KEY MACROINDICATORS
    • TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing focus on facial dermatology to aid market growth
    • TABLE 90 UK: KEY MACROINDICATORS
    • TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising number of plastic surgeons to drive market growth
    • TABLE 97 ITALY: KEY MACROINDICATORS
    • TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing demand for cosmetic procedures to drive market growth
    • TABLE 106 SPAIN: KEY MACROINDICATORS
    • TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
    • TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT
    • TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Japan accounted for largest share of APAC market in 2021
    • TABLE 126 JAPAN: KEY MACROINDICATORS
    • TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Rising healthcare expenditure to drive market growth in China
    • TABLE 135 CHINA: KEY MACROINDICATORS
    • TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Improving healthcare infrastructure to drive market growth in India
    • TABLE 140 INDIA: KEY MACROINDICATORS
    • TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
    • TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
    • TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
    • TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 154 MEXICO: KEY MACROINDICATORS
    • TABLE 155 BRAZIL: KEY MACROINDICATORS
    • TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
    • TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
  • 11.3 REVENUE ANALYSIS
    • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020
    • TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PARTICIPANTS
    • 11.5.4 PERVASIVE PLAYERS
    • FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
  • 11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
  • 11.7 COMPETITIVE BENCHMARKING
    • TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS
    • TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS
  • 11.8 COMPANY FOOTPRINT
    • TABLE 167 OVERALL FOOTPRINT OF COMPANIES
    • TABLE 168 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 169 REGIONAL FOOTPRINT OF COMPANIES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 DEALS
    • TABLE 170 DEALS, JANUARY 2019-MAY 2022
    • 11.9.2 PRODUCT LAUNCHES & APPROVALS
    • TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-MAY 2022
    • 11.9.3 EXPANSIONS
    • TABLE 172 EXPANSIONS, JANUARY 2019-MAY 2022

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.)
    • TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW
    • FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021)
    • 12.1.2 CUTERA, INC.
    • TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW
    • FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.3 CYNOSURE, INC.
    • TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW
    • 12.1.4 EL.EN. S.P.A.
    • TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW
    • FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021)
    • 12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC)
    • TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW
    • FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021)
    • 12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
    • TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW
    • FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021)
    • 12.1.7 DERMLITE
    • TABLE 179 DERMLITE: BUSINESS OVERVIEW
    • 12.1.8 BRUKER CORPORATION
    • TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.9 CARL ZEISS
    • TABLE 181 CARL ZEISS: BUSINESS OVERVIEW
    • FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021)
    • 12.1.10 GENESIS BIOSYSTEMS, INC.
    • TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW
    • 12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG
    • TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
    • 12.1.12 MICHELSON DIAGNOSTICS, LTD.
    • TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW
    • 12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP)
    • TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW
    • 12.1.14 FOTOFINDER SYSTEMS GMBH
    • TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW
    • 12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION)
    • TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW
    • FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.16 OLYMPUS CORPORATION
    • TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.17 CANDELA CORPORATION
    • TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW
    • FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.18 CANFIELD SCIENTIFIC, INC.
    • TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • 12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD.
    • TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS)
    • 12.2.2 AEROLASE
    • 12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL)
    • TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS